Neuland Laboratories announces executive leadership changes for family members

Neuland Laboratories Limited has announced a restructuring of its executive leadership, with Sucheth Rao Davuluri and Saharsh Rao Davuluri slated for new designations, effective April 1, 2026. Sucheth Rao Davuluri, currently vice chairman and CEO, will be re-designated as executive vice chairman, focusing on strategic areas including long-term planning, enterprise risk management, and CSR initiatives. Saharsh Rao Davuluri, currently vice chairman and managing director, will assume the role of CEO and managing director, taking responsibility for day-to-day operations and leveraging his experience in the CMS business.

The changes, approved by the board of directors on September 23, 2025, follow recommendations from the nomination and remuneration committee and aim to align with the organization's growth plans, ensuring a balanced focus on both short-term and long-term objectives. A transition period will commence immediately and conclude on March 31, 2026, to facilitate a seamless handover of operational responsibilities.

Both Sucheth Rao Davuluri and Saharsh Rao Davuluri will continue to report directly to the executive chairman, Dr. D. R. Rao. The re-designations are subject to shareholder approval and are detailed as per Regulation 30 of the SEBI Listing Regulations, as outlined in the company’s filings with the BSE and NSE. Sucheth Rao and Saharsh Rao are brothers and sons of Dr. D. Rama Mohan Rao, executive chairman.